Quel est le prix pour CardioGenics Holdings Inc (CGNH)

Le prix pour CardioGenics Holdings Inc (CGNH) est $0.0001

Quelle est la capitalisation boursière pour CardioGenics Holdings Inc (CGNH)

La capitalisation boursière pour CardioGenics Holdings Inc (CGNH) est $9.61K

Bénéfices de CardioGenics Holdings Inc (CGNH)

CardioGenics Holdings Inc. focuses on the creation and global distribution of diagnostic testing solutions within the in vitro diagnostics (IVD) sector, serving markets across the United States, Canada, Europe, and other international regions. A key offering is the QL Care Analyzer, an automated, self-contained, and portable point-of-care (POC) immunoassay device. This analyzer utilizes a unique, patented self-metering cartridge to perform immunoassay evaluations directly at the point of care. The company also provides a range of immunoassay panels specifically engineered to detect cardiac biomarkers in blood, which is vital for identifying heart attacks. Additionally, CardioGenics supplies paramagnetic beads, serving as crucial solid supports in heterogeneous immunoassay procedures for both clinical and research institutions. Established in 1997, the company was initially known as Jag Media Holdings, Inc. before officially changing its name to CardioGenics Holdings Inc. in 2009. Its corporate headquarters are situated in Mississauga, Canada.

Année	Bénéfices	Changez
Pas assez de données pour les dates fournies.

Année

Bénéfices

Changez

Pas assez de données pour les dates fournies.

Entreprise	Bénéfices	Différence de bénéfices	Pays
Thermo Fisher Scientific Inc. TMO.US	$7.61B	-	US
Danaher Corporation DHR.US	$4.76B	-	US
WuXi AppTec Co., Ltd. 603259.SS	-	-	CN
IDEXX Laboratories, Inc. IDXX.US	$1.42B	-	US
Natera, Inc. NTRA.US	$-252.70M	-	US

Entreprise

Bénéfices

Différence de bénéfices

Pays